Biotechnology Fund Class Fund Market Value

RYOAX Fund  USD 64.45  10.45  19.35%   
Biotechnology Fund's market value is the price at which a share of Biotechnology Fund trades on a public exchange. It measures the collective expectations of Biotechnology Fund Class investors about its performance. Biotechnology Fund is trading at 64.45 as of the 17th of December 2024; that is 19.35 percent increase since the beginning of the trading day. The fund's open price was 54.0.
With this module, you can estimate the performance of a buy and hold strategy of Biotechnology Fund Class and determine expected loss or profit from investing in Biotechnology Fund over a given investment horizon. Check out Biotechnology Fund Correlation, Biotechnology Fund Volatility and Biotechnology Fund Alpha and Beta module to complement your research on Biotechnology Fund.
Symbol

Please note, there is a significant difference between Biotechnology Fund's value and its price as these two are different measures arrived at by different means. Investors typically determine if Biotechnology Fund is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biotechnology Fund's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Biotechnology Fund 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Biotechnology Fund's mutual fund what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Biotechnology Fund.
0.00
11/17/2024
No Change 0.00  0.0 
In 30 days
12/17/2024
0.00
If you would invest  0.00  in Biotechnology Fund on November 17, 2024 and sell it all today you would earn a total of 0.00 from holding Biotechnology Fund Class or generate 0.0% return on investment in Biotechnology Fund over 30 days. Biotechnology Fund is related to or competes with Iaadx, Arrow Managed, Materials Portfolio, Rbc Microcap, Qs Large, Balanced Fund, and Scharf Global. Under normal circumstances, the fund invests substantially all of its net assets in equity securities of Biotechnology C... More

Biotechnology Fund Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Biotechnology Fund's mutual fund current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Biotechnology Fund Class upside and downside potential and time the market with a certain degree of confidence.

Biotechnology Fund Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Biotechnology Fund's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Biotechnology Fund's standard deviation. In reality, there are many statistical measures that can use Biotechnology Fund historical prices to predict the future Biotechnology Fund's volatility.
Hype
Prediction
LowEstimatedHigh
61.0964.4567.81
Details
Intrinsic
Valuation
LowRealHigh
60.2063.5666.92
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Biotechnology Fund. Your research has to be compared to or analyzed against Biotechnology Fund's peers to derive any actionable benefits. When done correctly, Biotechnology Fund's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Biotechnology Fund Class.

Biotechnology Fund Class Backtested Returns

Biotechnology Fund Class secures Sharpe Ratio (or Efficiency) of -0.0027, which signifies that the fund had a -0.0027% return per unit of risk over the last 3 months. Biotechnology Fund Class exposes twenty-seven different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Biotechnology Fund's Risk Adjusted Performance of 0.01, mean deviation of 1.33, and Downside Deviation of 3.35 to double-check the risk estimate we provide. The fund shows a Beta (market volatility) of 0.18, which signifies not very significant fluctuations relative to the market. As returns on the market increase, Biotechnology Fund's returns are expected to increase less than the market. However, during the bear market, the loss of holding Biotechnology Fund is expected to be smaller as well.

Auto-correlation

    
  -0.43  

Modest reverse predictability

Biotechnology Fund Class has modest reverse predictability. Overlapping area represents the amount of predictability between Biotechnology Fund time series from 17th of November 2024 to 2nd of December 2024 and 2nd of December 2024 to 17th of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Biotechnology Fund Class price movement. The serial correlation of -0.43 indicates that just about 43.0% of current Biotechnology Fund price fluctuation can be explain by its past prices.
Correlation Coefficient-0.43
Spearman Rank Test-0.65
Residual Average0.0
Price Variance10.93

Biotechnology Fund Class lagged returns against current returns

Autocorrelation, which is Biotechnology Fund mutual fund's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Biotechnology Fund's mutual fund expected returns. We can calculate the autocorrelation of Biotechnology Fund returns to help us make a trade decision. For example, suppose you find that Biotechnology Fund has exhibited high autocorrelation historically, and you observe that the mutual fund is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
   Current and Lagged Values   
       Timeline  

Biotechnology Fund regressed lagged prices vs. current prices

Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Biotechnology Fund mutual fund is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Biotechnology Fund mutual fund is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Biotechnology Fund mutual fund over time.
   Current vs Lagged Prices   
       Timeline  

Biotechnology Fund Lagged Returns

When evaluating Biotechnology Fund's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Biotechnology Fund mutual fund have on its future price. Biotechnology Fund autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Biotechnology Fund autocorrelation shows the relationship between Biotechnology Fund mutual fund current value and its past values and can show if there is a momentum factor associated with investing in Biotechnology Fund Class.
   Regressed Prices   
       Timeline  

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Biotechnology Mutual Fund

Biotechnology Fund financial ratios help investors to determine whether Biotechnology Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Biotechnology with respect to the benefits of owning Biotechnology Fund security.
Stocks Directory
Find actively traded stocks across global markets
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments